CBD Hemp Oil Product Potential Continues to Grow with Ongoing Scientific & Clinical Studies - Company Launches High CBD Hemp Oil for Sale in U.S.

CORAL SPRINGS, Florida, August 11, 2014 /PRNewswire/ --

The marijuana industry holds strong as new products hit market, companies test varying forms of cannabis therapies: Flameret Inc. (OTC: FLRE), GW Pharmaceuticals plc (NASDAQ: GWPH), Terra Tech Corp. (OTC: TRTC), American Green, Inc. (OTC: ERBB) and Easton Pharmaceuticals Inc. (OTC: EAPH)

Flameret Inc. (OTC: FLRE) announced today that it has launched Cannadol™, a hemp oil rich in CBD (cannabidiol) which will be sold in 1 ounce bottles through its wholly-owned subsidiary Royal Hemp Corporation. The product is available immediately online on Royal Hemp's website (http://www.royalhempcorporation.com) and each bottle of
Cannadol ™ includes an organic hemp oil infused with 200mg of CBD.

The product also includes about 1/10 of 1% THC (.1%), well beyond the legal threshold for THC content in the United States. The product will be marketed as a hemp oil dietary supplement rich in CBD and will be available for sale throughout the United States. The company is currently restricting sales outside of the United States. The product will be marketed through Royal Hemp Corporation, the company's recently announced Colorado wholly-owned subsidiary.

To read the full press release, please click here: http://financialnewsmedia.com/profiles/flre.html

Cannabidiol ("CBD") is one of at least 60 active cannabinoids identified in both cannabis and industrial hemp. It is present in both plants although the prevalence or total composition of CBD can vary greatly from strain to strain.

GW Pharmaceuticals plc (NASDAQ: GWPH), a biopharmaceutical company, together with its subsidiaries, is engaged in discovering, developing, and commercializing cannabinoid prescription medicines. The company operates through three segments: Sativex Commercial, Sativex Research and Development, and Pipeline Research and Development. The company primarily offers Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain, and neuropathic pain. It also focuses on the Phase III clinical development program of Sativex for use in the treatment of cancer pain. On last Friday, GWPH closed up .79% on over 381,000 shares traded.

Terra Tech Corp. (OTCQB: TRTC) subsidiary Edible Garden, an urban agricultural company, recently announced new retail outlets for their line of living produce. The company is now shipping 4" Living Herbs to A&P grocery stores throughout the Northeast. The Great Atlantic & Pacific Tea Company operates more than 300 stores operating under the A&P, Food Basics, The Food Emporium, Pathmark, Superfresh and Waldbaum's banners. "Growing up my parents shopped at A&P and I am now thrilled that the Edible Garden brand will be available at there retail stores," says Derek Peterson, CEO Terra Tech Corp. "We are pleased that retailers like A&P are supporting local farmers, helping create local jobs, and investing in their local communities." Edible Garden is actively pursuing additional retail partners to fill out their new 5-acre facility as well as the facilities of their cultivation partners in Florida and the Midwest. In addition the company has been experimenting with new produce in an effort to broaden their offerings to both current and potential retail partners.

American Green, Inc. (OTC Pink: ERBB) has made a move toward securing and expanding its business model regarding age-related purchases via any automated device. The company has entered into an agreement with Robert Tomassi, owner of intellectual property (IP) that pre-dates, and may supersede patents owned by competing companies operating in a similar market space. Mr. Tomassi's patents, numbered 6,711,465 and 7,493,190 were produced for the purpose of safely vending age-controlled, identity-specific items, all of which fits directly into American Green's business plan. While working in a family-related deli 14 years ago, Mr. Tomassi noted the easy access by minors of some controlled substances and was motivated to work on what became his accepted patent in this space. "It seemed like a good idea at the time, though most people thought I was a little crazy. As the market for safe access to controlled substances has increased, perhaps it was just an idea ahead of its time," says Tomassi of Levittown, PA.

Easton Pharmaceuticals Inc. (OTC Pink: EAPH) recently announced it has in keeping with its prior outlined timeline; made a site visit of the mPact -GROzone Antimicrobial System prior to shipping to one of the largest medical marijuana growers in the United States. As previously announced, Easton Pharmaceuticals has paid and acquired an initial ownership interest in AMFIL Technologies and its mPact -GROzone Antimicrobial System, with an option to purchase a much bigger 32.5% or more ownership interest in the company. Late last week, AMFIL's lead scientist and inventor provided an introductory viewing and presentation of a finished mPact -GROzone unit prior to being integrated into a commercially licensed, state of the art medical marijuana grow facility in Colorado. The mPact -GROzone Antimicrobial Systems is an exclusive application geared initially towards the Medical Marijuana Industry and marijuana growing/processing facilities as well as other pharmaceutical and food related applications.

FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup.

DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand five hundred dollars for news coverage of the current press release issued by Flameret Inc. by a non-affiliated third party.

FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.  

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company: FN Media Group, LLC
Contact email: [email protected]
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com

SOURCE FN Media Group, LLC